Newsroom
Wynveris receives CHF 40,000 from Venture Kick to advance first-in-class breast cancer therapy.
04.06.2026
Wynveris receives CHF 40,000 from Venture Kick to advance the development of the first receptor-selective FZD5 inhibitor for tripl ... more
StegaMatter receives CHF 40,000 from Venture Kick to convert technical validation into customer traction
04.06.2026
StegaMatter receives CHF 40,000 from Venture Kick to advance its technology for embedding verification information directly into p ... more
Inside the Jury Room: What Makes Investors Believe in a Founder by Emi Naganuma
02.06.2026
A startup pitch is rarely won by slides alone. Inside the Venture Kick jury room, experienced entrepreneurs and investors often fo ... more
Newsletter Archive
Momentum Beyond the Lab 🧪
Spring momentum across Swiss startups 🌱
A record 2025, and kicking bigger in 2026! 🚀
Press releases
Press review
1000 Unternehmen mit Venture Kick gegründet
Media contacts
For media enquiries, please email our communications team. If you have a general question about Venture Kick please visit our about us page.
Learn more about Venture Kick or download the latest annual report for detailed information.
